Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-08-11 Purchase |
2023-08-14 4:30 pm |
Sigilon Therapeutics Inc. | SGTX | ELI LILLY & Co Shenandoah Acquisition Corp 10% Owner |
1,718,493 | $14.92 | $25,639,916 | 100 (Direct) |
View |
| 2023-08-11 Sale |
2023-08-11 4:10 pm |
Sigilon Therapeutics Inc. | SGTX | Cox John Director |
341 | $0 | $0 | 0 (Direct) |
View |
| 2023-08-11 Sale |
2023-08-11 4:10 pm |
Sigilon Therapeutics Inc. | SGTX | Kowalsky Matthew Paul CHIEF OF STAFF AND CLO |
1,925 | $0 | $0 | 0 (Direct) |
View |
| 2023-08-11 Sale |
2023-08-11 4:10 pm |
Sigilon Therapeutics Inc. | SGTX | Yuan Qing Sarah CTOO |
2,884 | $0 | $0 | 0 (Direct) |
View |
| 2023-08-11 Sale |
2023-08-11 4:10 pm |
Sigilon Therapeutics Inc. | SGTX | Vivaldi Coelho Rogerio PRESIDENT AND CEO |
12,169 | $0 | $0 | 0 (Direct) |
View |
| 2023-08-11 Sale |
2023-08-11 4:10 pm |
Sigilon Therapeutics Inc. | SGTX | Pontes Josias CHIEF FINANCIAL OFFICER |
3,504 | $0 | $0 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-08-11 Equity Swap |
2023-08-15 4:15 pm |
N/A N/A |
Sigilon Therapeutics Inc. | SGTX | Flagship Ventures Fund V General Partner LLC Flagship Ventures Fund V L.P. Flagship Pioneering Special Opportunities Fund II L.P. Flagship Pioneering Special Opportunities Fund II General Partner LLC Flagship Pioneering Inc. AFEYAN NOUBAR 10% Owner |
797,720 | $14.92 | 0 (Indirect) |
View |
| 2023-07-27 Exercise |
2023-07-27 4:21 pm |
N/A N/A |
Sigilon Therapeutics Inc. | SGTX | Yuan Qing Sarah CTOO |
2,884 | $19.24 | 9,230 (Direct) |
View |
| 2023-07-27 Exercise |
2023-07-27 4:21 pm |
N/A 2032-03-06 |
Sigilon Therapeutics Inc. | SGTX | Yuan Qing Sarah CTOO |
2,884 | $0 | 9,230 (Direct) |
View |
| 2023-07-21 Exercise |
2023-07-24 7:45 pm |
N/A N/A |
Sigilon Therapeutics Inc. | SGTX | Pontes Josias CHIEF FINANCIAL OFFICER |
1,444 | $19.24 | 6,425 (Direct) |
View |
| 2023-07-21 Exercise |
2023-07-24 7:45 pm |
N/A 2032-02-17 |
Sigilon Therapeutics Inc. | SGTX | Pontes Josias CHIEF FINANCIAL OFFICER |
1,444 | $0 | 6,425 (Direct) |
View |
| 2023-07-21 Exercise |
2023-07-24 7:44 pm |
N/A N/A |
Sigilon Therapeutics Inc. | SGTX | Vivaldi Coelho Rogerio PRESIDENT AND CEO |
5,528 | $19.24 | 24,126 (Direct) |
View |
| 2023-07-21 Exercise |
2023-07-24 7:44 pm |
N/A 2032-02-17 |
Sigilon Therapeutics Inc. | SGTX | Vivaldi Coelho Rogerio PRESIDENT AND CEO |
5,528 | $0 | 24,126 (Direct) |
View |
Ownership |
2023-07-07 4:30 pm |
N/A N/A |
Sigilon Therapeutics Inc. | SGTX | ELI LILLY & Co Shenandoah Acquisition Corp 10% Owner |
0 | $0 | 211,110 (Direct) |
View |
| 2023-05-19 Option Award |
2023-05-22 4:20 pm |
N/A 2033-05-18 |
Sigilon Therapeutics Inc. | SGTX | RUFFOLO ROBERT R Director |
8,888 | $0 | 8,888 (Direct) |
View |
| 2023-05-19 Option Award |
2023-05-22 4:20 pm |
N/A 2033-05-18 |
Sigilon Therapeutics Inc. | SGTX | Patel Kavita Director |
8,888 | $0 | 8,888 (Direct) |
View |
| 2023-05-19 Option Award |
2023-05-22 4:20 pm |
N/A 2033-05-18 |
Sigilon Therapeutics Inc. | SGTX | Oesterle Stephen N. Director |
8,888 | $0 | 8,888 (Direct) |
View |
| 2023-05-19 Option Award |
2023-05-22 4:20 pm |
N/A 2033-05-18 |
Sigilon Therapeutics Inc. | SGTX | Cox John Director |
8,888 | $0 | 8,888 (Direct) |
View |
| 2023-05-19 Option Award |
2023-05-22 4:20 pm |
N/A 2033-05-18 |
Sigilon Therapeutics Inc. | SGTX | Shaff Eric D. Director |
8,888 | $0 | 8,888 (Direct) |
View |
| 2023-05-19 Option Award |
2023-05-22 4:20 pm |
N/A 2033-05-18 |
Sigilon Therapeutics Inc. | SGTX | Cole Douglas G. Director |
8,888 | $0 | 8,888 (Direct) |
View |
| 2023-02-28 Option Award |
2023-03-01 4:46 pm |
N/A 2033-02-27 |
Sigilon Therapeutics Inc. | SGTX | Kowalsky Matthew Paul CHIEF OF STAFF AND CLO |
165,000 | $0 | 165,000 (Direct) |
View |
| 2023-02-28 Option Award |
2023-03-01 4:43 pm |
N/A 2033-02-27 |
Sigilon Therapeutics Inc. | SGTX | Vivaldi Coelho Rogerio PRESIDENT AND CEO |
460,000 | $0 | 460,000 (Direct) |
View |
| 2023-02-28 Option Award |
2023-03-01 4:41 pm |
N/A 2033-02-27 |
Sigilon Therapeutics Inc. | SGTX | Pontes Josias CHIEF FINANCIAL OFFICER |
140,000 | $0 | 140,000 (Direct) |
View |
| 2023-02-28 Option Award |
2023-03-01 4:38 pm |
N/A 2033-02-27 |
Sigilon Therapeutics Inc. | SGTX | Ashton-Rickardt Philip CHIEF SCIENTIFIC OFFICER |
115,000 | $0 | 115,000 (Direct) |
View |
| 2023-02-28 Option Award |
2023-03-01 4:36 pm |
N/A 2033-02-27 |
Sigilon Therapeutics Inc. | SGTX | Yuan Qing Sarah CTOO |
115,000 | $0 | 115,000 (Direct) |
View |
Ownership |
2023-03-01 4:35 pm |
N/A N/A |
Sigilon Therapeutics Inc. | SGTX | Kowalsky Matthew Paul CHIEF OF STAFF AND CLO |
0 | $0 | 343,570 (Direct) |
View |
| 2022-05-26 Option Award |
2022-05-27 5:01 pm |
N/A 2032-05-25 |
Sigilon Therapeutics Inc. | SGTX | Shaff Eric D. Director |
8,888 | $0 | 8,888 (Direct) |
View |
| 2022-05-26 Option Award |
2022-05-27 5:01 pm |
N/A 2032-05-25 |
Sigilon Therapeutics Inc. | SGTX | Patel Kavita Director |
8,888 | $0 | 8,888 (Direct) |
View |
| 2022-05-26 Option Award |
2022-05-27 5:01 pm |
N/A 2032-05-25 |
Sigilon Therapeutics Inc. | SGTX | Oesterle Stephen N. Director |
8,888 | $0 | 8,888 (Direct) |
View |
| 2022-05-26 Option Award |
2022-05-27 5:00 pm |
N/A 2032-05-25 |
Sigilon Therapeutics Inc. | SGTX | RUFFOLO ROBERT R Director |
8,888 | $0 | 8,888 (Direct) |
View |
| 2022-05-26 Option Award |
2022-05-27 5:00 pm |
N/A 2032-05-25 |
Sigilon Therapeutics Inc. | SGTX | Cox John Director |
8,888 | $0 | 8,888 (Direct) |
View |
| 2022-05-26 Option Award |
2022-05-27 5:00 pm |
N/A 2032-05-25 |
Sigilon Therapeutics Inc. | SGTX | Story Brooke Director |
8,888 | $0 | 8,888 (Direct) |
View |
| 2022-05-26 Option Award |
2022-05-27 5:00 pm |
N/A 2032-05-25 |
Sigilon Therapeutics Inc. | SGTX | Cole Douglas G. Director |
8,888 | $0 | 8,888 (Direct) |
View |
| 2022-04-01 Option Award |
2022-04-04 4:50 pm |
N/A 2032-03-06 |
Sigilon Therapeutics Inc. | SGTX | Yuan Qing Sarah CTOO |
120,000 | $0 | 120,000 (Direct) |
View |
| 2022-02-18 Option Award |
2022-02-22 5:01 pm |
N/A 2032-02-17 |
Sigilon Therapeutics Inc. | SGTX | Ashton-Rickardt Philip CHIEF SCIENTIFIC OFFICER |
90,000 | $1.48 | 90,000 (Direct) |
View |
| 2022-02-18 Option Award |
2022-02-22 5:00 pm |
N/A 2032-02-17 |
Sigilon Therapeutics Inc. | SGTX | Pontes Josias ACTING CHIEF FINANCIAL OFFICE |
60,000 | $1.48 | 60,000 (Direct) |
View |